WebObjectives: To assess the prevalence of statin usage, intensity of statin therapy, and serum LDL cholesterol levels achieved in clinical diabetes mellitus population to analyze whether … WebConsider the use of moderate-intensity statins in patients without clinical ASCVD (i.e., primary prevention) with a 10-year ASCVD risk of 5% to < 7.5%. ... the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Inten Med. 2014;160:339-343. 3. Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC Guideline on ...
Natural Language Processing to Identify Reasons for Sex Disparity …
WebJun 30, 2024 · [1] [2] High-intensity statins such as atorvastatin 40-80 mg or rosuvastatin 20-40 mg usually result in an LDL-C reduction of around 50%. If target levels cannot be reached with maximally dosed high-intensity statins, ezetimibe should be added; for further reduction of LDL-C levels, a PCSK9-inhibitor is recommended. (Table 1) Main … WebJul 13, 2024 · The ACC/AHA guideline also introduced the idea of grouping statins by intensity (i.e., their expected LDL-C–lowering ability) ( TABLE 2 ). 20 Based on the treatment group (as defined above), the guideline recommends specific statin intensities for particular clinical situations ( TABLE 3 ). 20 Several treatment groups require calculation of an … farmers insurance property claims
UpToDate
Web• Choose dosing for % LDL-C reduction: high-intensity statin (≥ 50%), moderateintensit- y statin (30– ... Adapted from 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol . Table 2. 10-Year Risk Assessment for ASCVD . Ten-year risk is defined as the risk of developing a first ASCVD event (nonfatal MI, CHD death, fatal or nonfatal ... WebOct 1, 2024 · The ACC/AHA 2024 cholesterol guidelines state that in adults older than 75 years with diabetes mellitus, it may be reasonable to initiate statin therapy after a clinician–patient discussion of potential benefits and risks for prevention of ASCVD events. WebAge 40 to 75, 10-year ASCVD risk ≥ 7.5% (if unable to tolerate high-intensity statin) Age 40 to 75, 10-year ASCVD risk 5 to < 7.5%. Atorvastatin 10-20 mg. Fluvastatin XL 80 mg. Lovastatin 40 mg. Pitavastatin 2-4 mg. Pravastatin 40-80 mg. Rosuvastatin 5 … farmers insurance property and casualty